Drugs / AJU-A53
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07034781 | Aug → Nov 2025 overdue | type 2 diabetes mellitus | AJU Pharm Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT07044765 | Aug → Nov 2025 overdue | type 2 diabetes mellitus | AJU Pharm Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AJU-A53 | “Fixed-dose combination tablet (AJU-A53)” NCT07034781 ↗1“Fixed-dose combination tablet (AJU-A53)” NCT07044765 ↗ |